Lifitegrast

CAS 1025967-78-5

About the API

Trade name(s) Xiidra
Molecular Weight 615.48 g
Therapeutic category Ophthalmology
Available formulations Opthalmic

General Information

Lifitegrast is a lymphocyte function-associated antigen-1 (LFA-1) antagonist indicated for the treatment of the signs and symptoms of dry eye disease.